Loading viewer...
presentation
Format: PDF presentation
This April 2022 presentation by Ocugen discusses forward-looking statements regarding clinical trials and regulatory submissions for COVAXIN™.
investor_presentation
presentation
Adventus Mining Corporation
presentation
Marvell Technology
presentation
AdColony
presentation
Newmont Corporation